( in Million)
Particulars
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Audited / UnAudited
UnAudited
UnAudited
UnAudited
UnAudited
Net Sales
139484.1
155449.1
180350.7
170958.8
Total Expenditure
103565.8
120188
144668.2
136183.7
PBIDT (Excl OI)
35918.3
35261.1
35682.5
34775.1
Other Income
3206.7
5054.1
3617.1
3510.7
Operating Profit
39125
40315.2
39299.6
38285.8
Interest
13636.6
13186.5
12792.2
12132.1
Exceptional Items
NA
NA
NA
179.5
PBDT
25488.4
27128.7
26507.4
26333.2
Depreciation
12079
11620.5
11609.1
11162.8
Profit Before Tax
13409.4
15508.2
14898.3
15170.4
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
9956.39
11163.1
11326.9
12234.4
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
NA
NA
NA
NA
Net Profit
9956.39
11163.1
11326.9
12234.4
Minority Interest
-4223.5
-3259.5
-2024.6
-2632.6
Shares of Associates
1986.9
1290.8
1296.3
826.5
Misc. Expenses Written off
NA
NA
NA
NA
Consolidated Net Profit
7719.8
9194.4
10598.6
10428.3
Equity Capital
3195.6
3195.6
3195.6
3195.6
Calculated EPS
2.41
2.87
3.31
3.26
Calculated EPS (Annualised)
9.66
11.50
13.26
13.05
No of Public Share Holdings
1698080682
1697754282
1697754282
1697754282
% of Public Share Holdings
53.14
53.14
53.13
53.13
PBIDTM% (Excl OI)
25.75
22.68
19.78
20.34
PBIDTM%
28.04
25.93
21.79
22.39
PBDTM%
18.27
17.45
14.69
15.40